Table 3.
Differences of adjusted means of urinary arsenic species between subjects with and without skin lesions.
| Characteristics | Study Population | p-value | |
|---|---|---|---|
| Without Skin Lesions (n = 223) | With Skin Lesions (n = 79) | ||
| iAs (μg/g Cr) a | |||
| Crude b | 69.7 (62.4, 78.0) | 99.3 (78.7, 114.6) | 0.006 |
| Model 1 c | 68.1 (60.7, 76.4) | 95.9 (79.4, 115.6) | 0.003 |
| Model 2 d | 68.2 (60.7, 76.7) | 96.4 (79.1, 117.5) | 0.005 |
| Model 3 e | 70.6 (61.8, 80.9) | 99.1 (80.5, 121.9) | 0.006 |
| MMA (μg/g Cr) a | |||
| Crude b | 41.7 (34.7, 50.1) | 79.1 (58.1, 107.7) | 0.001 |
| Model 1 c | 40.2 (33.2, 48.6) | 80.2 (58.9, 109.4) | <0.001 |
| Model 2 d | 42.5 (35.0, 51.5) | 68.7 (49.8, 95.06) | 0.015 |
| Model 3 e | 42.9 (34.4, 53.5) | 69.3 (49.4, 97.3) | 0.016 |
| DMA (μg/g Cr) a | |||
| Crude b | 208.9 (182.0, 239.9) | 257.0 (204.2, 324.3) | 0.128 |
| Model 1 c | 195.9 (170.2, 225.4) | 264.2 (210.4, 331.9) | 0.030 |
| Model 2 d | 202.3 (175.4, 233.4) | 238.8 (187.9, 303.4) | 0.261 |
| Model 3 e | 206.1 (175.0, 242.7) | 243.8 (189.7, 313.3) | 0.255 |
| tAs (μg/g Cr) a | |||
| Crude b | 355.6 (317.7, 399.0) | 466.7 (385.5, 564.9) | 0.017 |
| Model 1 c | 339.6 (302.0, 381.9) | 476.4 (393.6, 575.4) | 0.003 |
| Model 2 d | 348.3 (309.0, 392.6) | 440.6 (361.4, 538.3) | 0.054 |
| Model 3 e | 354.0 (309.0, 406.4) | 447.7 (363.1, 552.1) | 0.057 |
a Values are adjusted mean and 95% confidence interval (95% CI); b Crude model; c Model 1 adjusted for sex. d Model 2 adjusted for variable in Model 1, age and BMI; e Model 3 adjusted for variables in Model 2, smoking and drinking.